An Exploration of Heart Failure Risk in Breast Cancer Patients Receiving Anthracyclines with or without Trastuzumab in Thailand: A Retrospective Study

Anthracycline-based regimens with or without anti-human epidermal growth factor receptor (HER) 2 agents such as trastuzumab are effective in breast cancer treatment. Nevertheless, heart failure (HF) has become a significant side effect of these regimens. This study aimed to investigate the incidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoodee, Jukapun, Sookprasert, Aumkhae, Sanguanboonyaphong, Phitjira, Chanthawong, Suthan, Seateaw, Manit, Subongkot, Suphat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395478/
https://www.ncbi.nlm.nih.gov/pubmed/34449564
http://dx.doi.org/10.3390/clinpract11030064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395478/
https://www.ncbi.nlm.nih.gov/pubmed/34449564
http://dx.doi.org/10.3390/clinpract11030064

Ejemplares similares